Cite
α1-Blockers and 5α-Reductase Inhibitors Are the Most Recommended Drugs in Treating Benign Prostatic Hyperplasia: An Evidence-Based Evaluation of Clinical Practice Guidelines
MLA
Xiao-Feng Xu, et al. “Α1-Blockers and 5α-Reductase Inhibitors Are the Most Recommended Drugs in Treating Benign Prostatic Hyperplasia: An Evidence-Based Evaluation of Clinical Practice Guidelines.” Frontiers in Pharmacology, vol. 11, Mar. 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....c415ed5f228e584270a36495de3dfc8a&authtype=sso&custid=ns315887.
APA
Xiao-Feng Xu, Guo-Xiong Liu, Cong Zhu, Xi-Min Qiao, Shao-Fu Yu, Tong Deng, & Ying-Hui Jin. (2020). α1-Blockers and 5α-Reductase Inhibitors Are the Most Recommended Drugs in Treating Benign Prostatic Hyperplasia: An Evidence-Based Evaluation of Clinical Practice Guidelines. Frontiers in Pharmacology, 11.
Chicago
Xiao-Feng Xu, Guo-Xiong Liu, Cong Zhu, Xi-Min Qiao, Shao-Fu Yu, Tong Deng, and Ying-Hui Jin. 2020. “Α1-Blockers and 5α-Reductase Inhibitors Are the Most Recommended Drugs in Treating Benign Prostatic Hyperplasia: An Evidence-Based Evaluation of Clinical Practice Guidelines.” Frontiers in Pharmacology 11 (March). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....c415ed5f228e584270a36495de3dfc8a&authtype=sso&custid=ns315887.